I agree that this site is using cookies. You can find further informations here.
X
Glenn Tillotson
121  results:
?
1

Penicillin-Resistant Streptococcus pneumoniae: Review of Mo..:

Axel Dalhoff ; Christina Krasemann ; Susanne Wegener.
Clinical Infectious Diseases.  32 (2001)  - p. S22-S29 , 2001
Link: https://www.jstor.org/st..
 
?
2

Antimicrobial Safety and Tolerability: Differences and Dile..:

Lionel A. Mandell ; Peter Ball ; Glenn Tillotson
Clinical Infectious Diseases.  32 (2001)  - p. S72-S79 , 2001
Link: https://www.jstor.org/st..
 
?
3

Evaluation of the Clinical Microbiology Profile of Moxiflox..:

Christina Krasemann ; Meyer, Jutta ; Glenn Tillotson
Clinical Infectious Diseases.  32 (2001)  - p. S51-S63 , 2001
Link: https://www.jstor.org/st..
 
?
4

Gut microbiome alpha diversity decreases in relation to bod..:

Panzer, Jonathan J. ; Maples, Catherine ; Meyer, Monica P....
American Journal of Infection Control.  52 (2024)  6 - p. 707-711 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Bacteroides and related species: The keystone taxa of the h..:

Shin, Jae Hyun ; Tillotson, Glenn ; MacKenzie, Tiffany N....
Anaerobe.  85 (2024)  - p. 102819 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Efficacy and Health-Related Quality of Life Impact of Fecal..:

Feuerstadt, Paul ; Allegretti, Jessica R. ; Dubberke, Erik R....
Infectious Diseases and Therapy.  13 (2024)  1 - p. 221-236 , 2024
Link: https://doi.org/10.1007/..
 
?
7

Microbiota-Based Live Biotherapeutic Products for Clostridi..:

Monday, Lea ; Tillotson, Glenn ; Chopra, Teena
Infection and Drug Resistance.  17 (2024)  - p. 623-639 , 2024
Link: https://doi.org/10.2147/..
 
?
8

Role of the microbiome in essential metabolism in the human..:

Chopra, Teena ; Hylemon, Phil ; Tillotson, Glenn
Open Forum Infectious Diseases.  10 (2023)  9 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
9

Two-year durability of REBYOTA™ (RBL), a live biotherapeuti..:

Orenstein, Robert ; Hecht, Gail ; Harvey, Adam..
Open Forum Infectious Diseases.  10 (2023)  9 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
10

The burden of CDI in the United States: a multifactorial ch..:

Feuerstadt, Paul ; Theriault, Nicolette ; Tillotson, Glenn
BMC Infectious Diseases.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
11

A narrative review of nontuberculous mycobacterial pulmonar..:

Hamed, Kamal A. ; Tillotson, Glenn
Expert Review of Respiratory Medicine.  17 (2023)  11 - p. 973-988 , 2023
Link: https://doi.org/10.1080/..
 
?
12

Editorial: Pharmacokinetics, pharmacodynamics (PK/PD) of an..:

Zeitlinger, Markus ; Tillotson, Glenn ; Echols, Roger
Frontiers in Pharmacology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
13

The Importance of a Broad Consortium of Bacteria for a Heal..:

Tillotson, Glenn ; Vedantam, Gayatri ; Shin, Jae Hyun.
Open Forum Infectious Diseases.  10 (2023)  11 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
14

Gut microbiota and microbiota-based therapies for Clostridi..:

Chopra, Teena ; Hecht, Gail ; Tillotson, Glenn
Frontiers in Medicine.  9 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
15

Fecal Microbiota, Live-jslm for the Prevention of Recurrent..:

Feuerstadt, Paul ; Crawford, Carl V. ; Tan, Xing...
Journal of Clinical Gastroenterology.  , 2023
Link: https://doi.org/10.1097/..
 
1-15